Treatment of Childhood Social Phobia
Completed · Phase 3 · Has a placebo group
Conditions studied: Social Phobia
In brief
This 4-year study will compare the long-term effectiveness of behavioral treatment, fluoxetine (Prozac®), and placebo for treatment of social phobia in children and adolescents.
Key facts
- Study ID
- NCT00043537
- Run by
- University of Central Florida
- People needed
- 139
- Starts
- 2001-04-01
- Expected to finish
- 2006-09-01
- Last updated by the study team
- 2013-08-01
Who can join
Age: 8 and older, up to 16. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Diagnosis of social phobia
You may not qualify if…
- Pervasive developmental disorders (PDD)
- Schizophrenia
- Major Depression
- IQ of less than 80
- Medical conditions contraindicating use of fluoxetine
Where it is running
- Maryland Center for Anxiety Disorders — University of Maryland, College Park, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.